Need Assistance?
  • US & Canada:
    +
  • UK: +

SP-B

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

SP-B is an antimicrobial peptide (AMP) isolated from Sus scrofa. It has activity against fungi.

Category
Functional Peptides
Catalog number
BAT-010956
Molecular Formula
C90H134N24O22
Molecular Weight
1904.21
Synonyms
Ala-Pro-Pro-Gly-Ala-Arg-Pro-Pro-Pro-Gly-Pro-Pro-Pro-Pro-Gly-Pro-Pro-Pro-Pro-Gly-Pro
Purity
>97%
Sequence
APPGARPPPGPPPPGPPPPGP
Storage
Store at -20°C
1. Alterations in SP-B and SP-C expression in neonatal lung disease
Lawrence M Nogee Annu Rev Physiol. 2004;66:601-23. doi: 10.1146/annurev.physiol.66.032102.134711.
The hydrophobic surfactant proteins, SP-B and SP-C, have important roles in surfactant function. The importance of these proteins in normal lung function is highlighted by the lung diseases associated with abnormalities in their expression. Mutations in the gene encoding SP-B result in severe, fatal neonatal lung disease, and mutations in the gene encoding SP-C are associated with chronic interstitial lung diseases in newborns, older children, and adults. This work reviews the current state of knowledge concerning the lung diseases associated with mutations in the SP-B and SP-C genes, and the potential roles of abnormal SP-B and SP-C expression and genetic variation in these genes in other lung diseases.
2. Fusion Expression and Fibrinolytic Activity of rPA/SP-B
Yi-Shan Tang, Xiao-Jun Zhang, Wan-Neng Wang, Ting Wang, Wu-Long Cao, Qiu-Han Zhang, Fu Chen Protein Pept Lett. 2021;28(9):1033-1042. doi: 10.2174/0929866528666210301151302.
Background: Pulmonary surfactant dysfunction is an important pathological factor in acute respiratory distress syndrome (ARDS) and pulmonary fibrosis (PF). Objective: In this study, the characteristics of recombinant mature surfactant protein B (SP-B) and reteplase (rPA) fusion protein maintaining good pulmonary surface activity and rPA fibrinolytic activity in acute lung injury cell model were studied. Methods: We studied the characteristics of SP-B fusion expression, cloned rPA gene and N-terminal rPA/C-terminal SP-B co-expression gene, and constructed them into eukaryotic expression vector pEZ-M03 to obtain recombinant plasmids pEZ-rPA and pEZ-rPA/SP-B. The recombinant plasmids was transfected into Chinese hamster ovary (CHO) K1 cells and the expression products were analyzed by Western Blot. Lipopolysaccharide (LPS) was used to induce CCL149 (an alveolar epithelial cell line) cell injury model. Fluorescence staining of rPA and rPA/SP-B was carried out with the enhanced green fluorescent protein (eGFP) that comes with pEZ-M03; the cell Raman spectroscopy technique was used to analyze the interaction between rPA/SP-B fusion protein and the phospholipid structure of cell membrane in CCL149 cells. The enzyme activity of rPA in the fusion protein was determined by fibrin-agarose plate method. Results: The rPA/SP-B fusion protein was successfully expressed. In the CCL149 cell model of acute lung injury (ALI), the green fluorescence of rPA/SP-B is mainly distributed on the CCL149 cell membrane. The rPA/SP-B fusion protein can reduce the disorder of phospholipid molecules and reduce cell membrane damage. The enzyme activity of rPA/SP-B fusion protein was 3.42, and the fusion protein still had good enzyme activity. Conclusion: The recombinant eukaryotic plasmid pEZ-rPA/SP-B is constructed and can be expressed in the eukaryotic system. Studies have shown that rPA/SP-B fusion protein maintains good SP-B lung surface activity and rPA enzyme activity in acute lung injury cell model.
3. The localization of SP-B and influences of lipopolysaccharide on it
W-N Wang, J-H Zhou, P Wang, X-J Zhang Eur Rev Med Pharmacol Sci. 2016 Jun;20(11):2338-45.
Objective: Surfactant protein B (SP-B) is the only essential protein component of lung surfactant, the relationship between localization and function is very close. The localization of rat SP-B and influences of lipopolysaccharide (LPS) on it were investigated. Materials and methods: The localization of SP-B protein in lung tissue was detected by immunofluorescence after challenged with intratracheal instillation of LPS. The constructed recombinant plasmid pEGFP-N2-SP-B was transfected with CCl-149 cell lines by liposome to explore the localization of SP-B in alveolar type II epithelial cells. Furthermore, the expression and function of SP-B were analyzed with LPS stimulating. Results: The proteins SP-B and SP-C showed the same pattern of expression in normal lung, and distributed in the alveolar cavity, LPS can directly affect the expression of SP-B in vivo, contrast to SP-B, the LPS-induced influences on SP-C is little. SP-B had the membrane embedded features and localized on the cell surface of CCL149 in vitro, but was influenced by LPS. Conclusions: It is confirmed that the expression and membrane function of SP-B were decreased by stimulating LPS in lung tissue and alveolar type II epithelial cells.
Online Inquiry
Verification code
Inquiry Basket